Home›Companies›Biotech & Pharma›Aether Therapeutics

Aether Therapeutics Inc.

Updated Oct 29, 2026·Latest SEC filing Jan 19, 2024·Suggest an edit

About Aether Therapeutics

Aether Therapeutics is a private company based in Austin, Texas. It has reported $4,078,010 raised in one offering on Form D since January 2024. Its chief executive is John Harris.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 5, 2024Jan 19, 2024$4,078,010of $6.5M target1$4.0MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Aether Therapeutics's Form D filed Jan 19, 2024.

JH
John Harris
Chief Executive Officer and director
EO
Eric Olson
Director
WS
JS
Jon Saxe
Executive officer and director

Sources

  1. SECAether Therapeutics Inc. filing history